Immune-inflammatory diseases under your skin

Our aim

We are looking for partners to help us to identify, validate or test new targets for the treatment of chronic immune-inflammatory diseases of the skin.

Psoriasis, atopic dermatitis or pemphigus vulgaris are examples of chronic immune-inflammatory skin diseases associated with significant comorbidities that have a profound impact in the quality of life of patients. They are our focus.

Many chronic immune-inflammatory diseases, irrespective of the organ affected (joints, CNS, gut or skin), share common mechanisms, pathways and players: psoriasis has therapies in common with multiple sclerosis and rheumatoid arthritis; atopic dermatitis with asthma; pemphigus with lupus, to name a few.

Regardless of your field of expertise, if you are a scientist with an idea (target, pathway, therapy) that you think might be of use in a dermatological disease, share it with us and we will explore it, together.

Who is this for

This call is addressed to scientists affiliated to Universities, Research Centers, Start-ups, Biotechs, and Pharma companies.

Collaborative framework

  • Submitted proposals may become eligible to receive a research grant
    • Funding will be granted to those submissions that are deemed valuable and are approved by Almirall
    • Research grant up to € 250000. Final amount will be consistent with the proposed research project, and it may be provided in one or several installments
  • Intellectual property rights remain with the applicant
    • You will retain ownership of any intellectual property you may bring or develop
  • Additional scientific support will be provided on an ad-hoc basis
    • Mentorship by Almirall experts to advance the initial proposal to meet project criteria
    • Technology platforms to assist in your target validation
    • Pharmacological tools
    • Advise on intellectual property matters
  • A designated contact person will help you should you have questions

Collaboration process

  • Proposal submission
    • The first step is for you to create an account on AlmirallShare Innovation platform, which is a secure site to store and manage your proposals
    • The submission period is from July 25th, 2019 to October 31st, 2019
    • Please include an outline of your idea (max. 300 words) and a detailed description of your proposal including publications that support it
    • All the initial information provided under the proposal should be non-confidential
  • Submissions will be handled following all applicable local compliance requirements
    • For Investigator Sponsored Trial (IST) requests from individual healthcare professionals, please submit through the standard local channels
  • Proposal evaluation and selection
    • A team of Almirall scientific experts will evaluate your proposal as soon as it will be received
    • You will receive in writing Almirall’s decision regarding your proposal within 4-8 weeks after submission
    • If your proposal has been selected, a member of the Shared Innovation Team will reach out to you to initiate a collaboration agreement that will reflect the experimental activities supported and the funding amount
    • An Almirall scientist will be assigned to collaborate with you on project definition as well as project follow-up

For scientists at Universities, public and private Research Institutions, Biotechs and Start-ups

Open from 25/07/19 to 04/11/19
Research grants up to € 250000